LADENBURG THALMANN FINANCIAL SERVICES INC. - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 60 filers reported holding CASI PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$6,000
-14.3%
2,001
-2.2%
0.00%
Q3 2019$7,000
+16.7%
2,0460.0%0.00%
Q2 2019$6,0000.0%2,0460.0%0.00%
Q1 2019$6,000
-25.0%
2,0460.0%0.00%
Q4 2018$8,000
-11.1%
2,0460.0%0.00%
Q3 2018$9,000
+12.5%
2,0460.0%0.00%
Q2 2018$8,0000.0%2,0460.0%0.00%
Q1 2018$8,0002,046
+4446.7%
0.00%
Q4 2017$0450.0%0.00%
Q3 2017$0450.0%0.00%
Q2 2017$0
-100.0%
45
-91.0%
0.00%
Q1 2017$1,0000.0%499
-52.2%
0.00%
Q4 2016$1,0000.0%1,0450.0%0.00%
Q3 2016$1,000
-50.0%
1,045
-46.5%
0.00%
Q2 2016$2,0000.0%1,9540.0%0.00%
Q1 2016$2,000
+100.0%
1,954
+104.8%
0.00%
Q4 2015$1,0000.0%9540.0%0.00%
Q3 2015$1,000
-50.0%
9540.0%0.00%
Q2 2015$2,000
+100.0%
9540.0%0.00%
Q1 2015$1,0000.0%9540.0%0.00%
Q4 2014$1,000
-50.0%
9540.0%0.00%
Q3 2014$2,0009540.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$19,934,00016.36%
Wellington Shields & Co., LLC 1,585,609$3,964,0001.74%
Wellington Shields Capital Management, LLC 1,321,745$3,304,0000.53%
Ikarian Capital, LLC 1,039,910$2,600,0000.21%
Zebra Capital Management LLC 50,658$127,0000.18%
BOOTHBAY FUND MANAGEMENT, LLC 139,183$348,0000.02%
Manatuck Hill Partners, LLC 15,090$38,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 205,200$513,0000.01%
IHT Wealth Management, LLC 26,000$65,0000.01%
Vident Investment Advisory, LLC 67,540$169,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders